Bone Marrow TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningStem CellsBone Marrow PurgingLiver TransplantationWhole-Body IrradiationHematopoietic Stem CellsBone and BonesCombined Modality TherapyCyclophosphamideGraft SurvivalPeripheral Blood Stem Cell TransplantationTransplantation ChimeraKidney TransplantationBusulfanTissue DonorsTreatment OutcomeLeukemiaLymphoma, Non-HodgkinHematologic NeoplasmsRemission InductionRecurrenceMelphalanCarmustineAnemia, AplasticHistocompatibility TestingBone Marrow DiseasesLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsHematopoiesisTransplantation, IsogeneicTime FactorsHistocompatibilityMesenchymal Stem Cell TransplantationHeart TransplantationImmunosuppressive AgentsSurvival AnalysisCell TransplantationEtoposideRetrospective StudiesGraft RejectionMultiple MyelomaLung TransplantationColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaHodgkin DiseaseTransplantation ImmunologyCord Blood Stem Cell TransplantationCell DifferentiationCytarabineMice, Inbred C57BLLeukemia, MyeloidSurvival RateHepatic Veno-Occlusive DiseaseBone Marrow ExaminationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFollow-Up StudiesDisease-Free SurvivalImmunosuppressionHematologic DiseasesBone RemodelingAntigens, CD34Organ TransplantationMyelodysplastic SyndromesHematopoietic Stem Cell MobilizationAcute DiseaseGranulocyte Colony-Stimulating FactorSalvage TherapyBone Marrow NeoplasmsT-LymphocytesCells, CulturedRadiation ChimeraActuarial AnalysisHLA AntigensLymphomaLymphocyte DepletionGraft vs Leukemia EffectMyeloablative AgonistsFlow CytometryCyclosporineThiotepaVincristinePrognosisIslets of Langerhans TransplantationLymphocyte TransfusionTransplantationCell SeparationAdult Stem CellsGraft vs Tumor EffectPancreas TransplantationBone DensityLeukocyte CountMesenchymal Stromal Cells